olaparib,abiraterone
astrazeneca,merck
['gu ', 'docetaxel', 'brca', 'crpc', 'abira', 'olaparib', 'propel', 'abiraterone', 'cam ']
asco gu 2023 day 1 take home: parpi's! 3) propel: olaparib (parpi) + abiraterone improved rpfs vs abiraterone alone in 1st line mcrpc irrespective of hrr status #ascogu23 #ascogu2023 #ascogu 
Genitourinary Medical Oncologist